KNSA Institutional Ownership

KINIKSA PHARMACEUTICALS INTE

Latest close $77.59 as of Aug 5, 2026

Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.

Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.

Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Jul 29, 2026

Public consensus preview Mixed positioning 51/100 institutional research score

2 tracked institutions Latest filing Jul 29, 2026

1 accumulating, 1 reducing across 2 comparable institutions.

Accumulating1

Unchanged0

Reducing1

Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$26.27 52-week high$64.81

Latest close $77.59 100.0% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Jun 30, 2026

Fidelity / FMR May 6, 2026 filed

BlackRock Jul 29, 2026 filed

Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 5 parsed filing(s) · 2 older require more history access

Holder	Observed / filed	Reported change	Shares	Ownership	Observation	Filing	Latest
BlackRock CIK0002012383	Jun 30, 2026 observed Jul 29, 2026 filed · 29d Initial Schedule 13G	Initial Schedule 13G	2.5M -1.3M	12.00% +2.60 pts	$63.95	$80.92	$77.59
Fidelity / FMR CIK0000315066	Mar 31, 2026 observed May 6, 2026 filed · 36d Schedule 13G amendment	Reported accumulation	6.8K +1.9K	14.80% +2.80 pts	$48.15	$58.23	$77.59
Fidelity / FMR CIK0000315066	Feb 27, 2026 observed Mar 6, 2026 filed · 7d Initial Schedule 13G	Initial Schedule 13G	4.9K	12.00%	$44.49	$46.16	$77.59

Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

SEVN SEVEN HILLS REALTY TRUST 51/100 Mixed positioning CEVA CEVA INC 51/100 Mixed positioning CARR CARRIER GLOBAL CORP 51/100 Mixed positioning REXR Rexford Industrial Realty, Inc. 51/100 Mixed positioning

Recent multi-institution accumulation

TVTX Travere Therapeutics, Inc. 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026